📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Clarient

1.1 - Company Overview

Clarient Logo

Clarient

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cancer diagnostic testing and oncology diagnostic services in the United States, partnering with local pathologists and oncologists to bring the standard of care back to their communities, using multiple technologies to clarify complex problems, help diagnose cancer cases, and provide insight.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Clarient

Kleo Pharmaceuticals Logo

Kleo Pharmaceuticals

HQ: United States Website
  • Description: Provider of small-molecule therapeutics in development, including Antibody Recruiting Molecules (ARMs) and Synthetic Antibody Mimics (SyAMs), to treat cancer, infectious diseases, and other indications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kleo Pharmaceuticals company profile →
Haystack Oncology Logo

Haystack Oncology

HQ: United States Website
  • Description: Provider of tumor-informed liquid biopsy and ctDNA detection solutions to diagnose minimum residual disease and inform therapy decisions, including Haystack MRD to detect residual/recurrent/resistant disease; Haystack Duo Chemistry for sensitive detection of low-abundance mutant DNA; and clinical trial collaborations to evaluate therapeutic response.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Haystack Oncology company profile →
Jounce Therapeutics Logo

Jounce Therapeutics

HQ: United States Website
  • Description: Provider of first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors, driven by a proprietary product engine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jounce Therapeutics company profile →
Acepodia Logo

Acepodia

HQ: United States Website
  • Description: Provider of cancer cell therapies and platform technology, including ACC (Antibody-Cell Conjugation) to attach tumor-targeting antibodies to immune cells without genetic engineering; off-the-shelf allogeneic γδ2 T cell therapies; and ACC-γδ2 T cell candidates ACE1831 (CD20), ACE2016 (EGFR), and ACE1708 (PD-L1).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acepodia company profile →
Advanced Accelerator Applications Logo

Advanced Accelerator Applications

HQ: France Website
  • Description: Provider of targeted radioligand therapies and precision imaging radioligands, offering LUTATHERA: a radioligand therapy using lutetium Lu 177 dotatate for treating tumors; PLUVICTO: a therapeutic radioligand containing lutetium Lu 177 vipivotide tetraxetan; diagnostic PET imaging kits NETSPOT, LOCAMETZ, and SOMAKIT TOC; and LysaKare to reduce renal radiation exposure during peptide-receptor radionuclide therapy with LUTATHERA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Advanced Accelerator Applications company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Clarient

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Clarient

2.2 - Growth funds investing in similar companies to Clarient

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Clarient

4.2 - Public trading comparable groups for Clarient

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Clarient

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Clarient

What does Clarient do?

Clarient is a provider of cancer diagnostic testing and oncology diagnostic services in the United States, partnering with local pathologists and oncologists to bring the standard of care back to their communities, using multiple technologies to clarify complex problems, help diagnose cancer cases, and provide insight.

Who are Clarient's competitors?

Clarient's competitors and similar companies include Kleo Pharmaceuticals, Haystack Oncology, Jounce Therapeutics, Acepodia, and Advanced Accelerator Applications.

Where is Clarient headquartered?

Clarient is headquartered in United States.

How many employees does Clarient have?

Clarient has 1,000 employees 🔒.

When was Clarient founded?

Clarient was founded in 2010 🔒.

What sector and industry vertical is Clarient in?

Clarient is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Clarient

Who are the top strategic acquirers in Clarient's sector and industry

Top strategic M&A buyers and acquirers in Clarient's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Clarient?

Top strategic M&A buyers groups and sectors for Clarient include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Clarient's sector and industry vertical

Which are the top PE firms investing in Clarient's sector and industry vertical?

Top PE firms investing in Clarient's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Clarient's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Clarient's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Clarient's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Clarient include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Clarient's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Clarient?

The key public trading comparables and valuation benchmarks for Clarient include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Clarient for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Clarient with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Clarient's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Clarient with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Clarient's' sector and industry vertical?

Access recent funding rounds and capital raises in Clarient's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Clarient